OneCell Diagnostics is now 1Cell.Ai
Patient: 7-year-old male with glioblastoma multiforme (WHO Grade IV) post–partial resection and chemoradiotherapy Clinical Testing:Alterations: TP53, CDKN2A, LATS1, ATM, BRCA2,
Patient: 55 years – Female with metastatic triple-negative breast carcinoma (ER–, PR–, HER2 1+) Clinical Testing:Alterations: TP53 (p.D281E), MSH3 (p.R454*), PIK3CA (p.E542K),
Patient: 52 years – Female with recurrent metastatic breast carcinoma (ER+, HER2–) Clinical Testing:Alterations: ESR1 (mutation), PIK3CA (VUS)Genes: ESR1, PIK3CATreatment Options: Sequential use of
